To view a copy of this licence, visit About this article Cite this article Zhang, L., Chen, X., Xu, Y
Med Sci Monit 2011;17:BR35-41.ArticlePubMedPMC 104
Over time, researchers noticed that GLP-1 agonists seemed to decrease appetite and promote weight loss
Snyder concludes
Key Facts About Retatrutide 30mg Compound: Retatrutide Research identifier: LY3437943 Research class: Triple receptor agonist model Pathways studied: GLP-1, GIP, and glucagon receptor pathways Common search terms: GLP-3, GLP-R, triple agonist peptide, next-generation GLP-1 research compound Format: Lyophilized research peptide Use: Laboratory research only Retatrutide 30mg Research Compound Overview Retatrutide 30mg is a high-purity, batch-verified research peptide supplied for laboratories requiring consistency, analytical precision, traceability, and controlled sourcing
Alcohol Consumption: Emerging research suggests GLP-1 agonists may also influence alcohol consumption, with preliminary findings indicating a potential reduction in binge drinking, alcohol cravings, and desire to drink among users
